BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

BridgeBio Pharma Inc Extraordinary Shareholders Meeting Transcript

Jan 19, 2021 / 06:00PM GMT
Release Date Price: $69.38 (+1.12%)
Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director

Will the meeting please come to order? I'm Neil Kumar, Chief Executive Officer of BridgeBio Pharma. Along with my fellow Directors and Executive Officers of the company, I'd like to welcome you to this Special Meeting of Stockholders. We appreciate your attendance, your interest and, most importantly, your support of BridgeBio.

This Special Meeting with Stockholders is being held pursuant to the bylaws of the company and the notice of special meeting and joint proxy statement and prospectus sent to all stockholders as of close of business on December 8, 2020, the record date. Due to the public health impact of the coronavirus outbreak, the Special Meeting is being held by remote communication only in a virtual meeting format.

Stockholders may submit questions that relate to the purpose of this meeting at any time during the meeting in the space provided on the meeting portal. After dealing with a few procedural matters, we will take up items to be acted upon.

I'd now like to turn the meeting over to Brian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot